System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Jan van der Meulen is an expert in Urology at London School of Hygiene & Tropical Medicine (United Kingdom). As of October 2026, ScienceLeadR ranks Jan van der Meulen in the top 1% of experts worldwide for Epidemiologic Studies. Jan van der Meulen has authored 523 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 1,647 (community average: 125). How the SLR is computed.

LeadR Profile

Jan van der Meulen London School of Hygiene & Tropical Medicine United Kingdom
1 647 ScienceLeadR Reputation 1647

Unlock

Register Login
Network Map

Urology

Subspecialties: Oncology - Public Health - Radiotherapy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026
Source: PubMed

London School of Hygiene & Tropical Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 523

Citations

Citations: 22 425 1st author: 18 Last author: 133 Unique author: 10

Main journals

BJU Int 25
BMJ Open 17
J Urol 17
Eur Urol 13
PLoS One 13

Best Journals

Lancet Oncol 8
Lancet 5
BMJ 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Improved survival in newly diagnosed metastatic prostate cancer: a National Prostate Cancer Audit study.
PMID 42845147 — mortality, neoplasms, prostate, prostatic neoplasms		BJU Int20260
The National Ovarian Cancer Audit (NOCA) 2026 State of the Nation Report: Key Findings, Recommendations, and Quality Improvement Intervention to Improve the Quality of Ovarian Cancer Care in England and Wales.
PMID 42828886 — ovary, neoplasms, ovarian neoplasms, quality improvement		Clin Oncol (R Coll Radiol)20260
Unmasking inequity: emergency presentations in ovarian cancer care.
PMID 42753758 — emergencies, ovary, neoplasms, ovarian neoplasms, socioeconomic factors		Lancet Top journal20260
The effect of older age and stage on risk of recurrence and mortality following curative resection, in a national cohort of patients with colorectal cancer.
PMID 42481685 — mortality, neoplasms, aged, therapeutics, colorectal neoplasms		Br J Cancer20260
Ovarian cancer diagnosis within 28 days after an emergency admission to hospital: national population-based study of patient risk factors and cancer characteristics using routinely collected data in England.
PMID 42445111 — emergencies, ovary, neoplasms, ovarian neoplasms, risk factors, diagnosis		BMJ Oncol20261

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Director: 1

By phase:

Phase 3 3
Phase 2 2
Phase 1 1

By status:

Completed 4
Recruiting 1
Unknown 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 2
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED
2025-523443-35-00 — eye, growth, safety, solutions, nerve growth factor, ophthalmic solutions, therapeutics, pharmaceutical vehicles		Phase 3Recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS